Prot# HuLuc63-1701: Phase 1, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 (Humanized anti-CS1 Monoclonal IgG1 Antibody) in Subjects with Advanced Multiple Myeloma

Project: Research project

Project Details

StatusFinished
Effective start/end date3/20/07 → 9/1/11

Funding

  • PDL BioPharma, Inc. (HuLuc63-1701)